This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC. The primary endpoint is PFS. Secondary points contains：ORR、OS、Qol.
This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC.